Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma.
Jun 2008 - J. Immunother.; 31(6):1524-9557 [PMID:18528294]
[Redman BG] [Chang AE] [Whitfield J] [Esper P] [Jiang G] [Braun T] [Roessler B] [Mulé JJ]

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.
Apr 2008 - J. Immunother.; 31(4):1524-9557 [PMID:18391761]
[Teitz-Tennenbaum S] [Li Q] [Okuyama R] [Davis MA] [Sun R] [Whitfield J] [Knibbs RN] [Stoolman LM] [Chang AE]